Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs

Objective: In October 2003, the U.S. Food and Drug Administration (FDA) issued a public health advisory about the risk of suicidality in pediatric patients taking selective serotonin reuptake inhibitors (SSRIs) for depression. This study used data from a large national pediatric cohort to examine pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of psychiatry 2007-06, Vol.164 (6), p.884-891
Hauptverfasser:	Libby, Anne M., Brent, David A., Morrato, Elaine H., Orton, Heather D., Allen, Richard, Valuck, Robert J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult and adolescent clinical studies Advisory Committees Antidepressants Biological and medical sciences Children & youth Clinical medicine Cohort Studies Data Collection Depression Depressive Disorder, Major - diagnosis Depressive Disorder, Major - drug therapy Depressive Disorder, Major - epidemiology Drug and Narcotic Control Drug Prescriptions - statistics & numerical data Drug therapy Drug Utilization Health Policy Humans Managed Care Programs - statistics & numerical data Medical sciences Medical treatment Mental depression Mood disorders Patients Pediatrics Pediatrics - statistics & numerical data Pharmaceuticals Physicians, Family - statistics & numerical data Practice Patterns, Physicians' - standards Prescriptions Primary care Psychiatry - statistics & numerical data Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Risk factors Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - therapeutic use Side effects Studies Suicide Suicide - prevention & control Suicide - psychology Suicides & suicide attempts United States - epidemiology United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!